The role of the Ca2+/phospholipid-dependent protein kinase C (PKC) in cholinergic potentiation of insulin release was investigated by measuring islet PKC activity and insulin secretion in response to carbachol (CCh), a cholinergic agonist. CCh caused a dose-dependent increase in insulin secretion from cultured rat islets at stimulatory glucose concentrations ( > 7 mM), with maximal effects observed at 100 /tM. Short-term exposure (5 min) of islets to 500 ,tM-CCh at 2 mm-or 20 mM-glucose resulted in redistribution of islet PKC activity from a predominantly cytosolic location to a membrane-associated form. Prolonged exposure (> 20 h) of islets to 200 nM-phorbol myristate acetate caused a virtual depletion of PKC activity associated with the islet cytosolic fraction. Under these conditions of PKC down-regulation, the potentiation of glucosestimulated insulin secretion by CCh (500 /tM) was significantly decreased, but not abolished. CCh stimulated the hydrolysis of inositol phospholipids in both normal and PKC-depleted islets, as assessed by the generation of radiolabelled inositol phosphates. These results suggest that the potentiation of glucoseinduced insulin secretion by cholinergic agonists is partly mediated by activation of PKC as a consequence of phospholipid hydrolysis.
INTRODUCTION
Cholinergic muscarinic agonists, including the endogenous neurotransmitter acetylcholine (ACh) and its synthetic non-hydrolysable analogue carbachol (CCh), enhance glucose-induced insulin secretion from pancreatic fl-cells (Malaisse et al., 1967; Gagerman et al., 1978; Nenquin et al., 1984; Hughes et al., 1987) . They do so by interacting directly with specific muscarinic recep- tors in the fl-cell plasma membrane, recently identified as being of a glandular M2 subtype Verspohl et al., 1988) . However, their mode of action in modulating insulin release is still uncertain. Cholinergic agonists have effects on f8-cell membrane potential and ionic conductances (Gagerman et al., 1978; Nenquin et al., 1984; Mathias et al., 1985; and they also stimulate hydrolysis of phosphatidylinositol 4,5-bisphosphate in both islets (Best & Malaisse, 1983; Morgan et al., 1985; Hallberg, 1986) and insulin secreting tumour cells (Wollheim & Biden, 1986) . Inositol phospholipid hydrolysis results in the generation ofinositol 1 ,4,5-trisphosphate and diacylglycerol (DAG), which can liberate intracellular Ca2l and activate Ca2+/phospholipid-dependent protein kinase C (PKC) respectively, in a variety of cell types (Berridge & Irvine, 1984; Nishizuka, 1984) . PKC has been identified in islets and in insulin-secreting cell lines (Tanigawa et al., 1982; Lord & Ashcroft, 1984; Persaud et al., 1989) , and its activation in vitro by DAG analogues or phorbol myristate acetate (PMA), a tumour-promoting phorbol ester, results in stimulation of insulin secretion (Hubinont et al., 1984; Jones et al., 1985) . We have previously reported that prolonged exposure of rat islets of Langerhans to PMA down-regulates total cellular PKC activity (Hii et al., 1987) . In the present study we have investigated the effects of PKC down-regulation on the ability of CCh to augment glucose-induced-insulin release, in order to evaluate the importance of PKC in the mode of action of cholinergic agonists as insulin secretagogues. mycin/ml, 100 units of penicillin/ml and 100O (v/v) foetal-calf serum, in a humidified atmosphere of CO2/air (1: 19) . For experiments on PKC down-regulation, islets were cultured in the presence of either 200 nM-PMA or 200 nm of the inactive phorbol ester 4ccPDD. After 20-24 h, the islets were harvested and washed three times in a bicarbonate-buffered (pH 7.4) physiological salt solution (Gey & Gey, 1936) supplemented with 2 mMglucose, 2 mM-CaC12 and 0.5 mg of albumin/ml. Insulin secretion Groups of three islets were incubated at 37°C in 0.6 ml of the bicarbonate-buffered salt solution containing the test substances of interest. After 60 min, islets were pelleted by brief centrifugation (9000 g, 15 s) and the supernatant was removed and stored at -20°C until determination of insulin content by radioimmunoassay . For studies of the dynamic regulation of insulin release, groups of 100 cultured islets were loaded on to nylon filters (1 um pore size) and perifused (37°C, 1 ml/min) with Gey & Gey (1936) buffer supplemented with 2 mm-or 20 mM-glucose and/or CCh. Fractions were collected at 15 s or 2 min intervals and analysed for insulin content by radioimmunoassay.
EXPERIMENTAL

PKC purification and assay
After overnight culture in RPMI 1640 alone, or in the presence of either 4aPDD or PMA, groups of 400-500 islets were thoroughly washed, incubated for 5 min with 500,uM-CCh if appropriate, resuspended in 200,ul of buffer A (20 mM-Tris/HCl, 2 mM-EDTA, 0.5 mM-EGTA, 50,ug of leupeptin/ml, 1 mM-phenylmethanesulphonyl fluoride and 0.1 00 mercaptoethanol) and sonicated (MSE Soniprobe, 4 x 15 s). Membranes were separated from cytosol by centrifugation at 30000 g for 30 min at 4°C, the resulting pellets were dispersed by sonication and enzyme activity was solubilized by incubation for 30 min (4°C) in the presence of 1 00 Nonidet P-40. Cytosol and membrane extracts were applied to DEAE-cellulose DE52 columns (0.2 ml), and PKC activity was eluted with buffer A supplemented with 120 mM-NaCl. PKC activity in eluate samples was assayed by measuring incorporation of 32P from [y-32P]ATP into histone type III-S, as described in detail by Persaud et al. (1989 (200 nM) . Islets were washed three times with bicarbonate-buffered physiological salt solution (4°C) containing 10 mM-LiCl, 2 mM-glucose and 1 mMinositol (unlabelled). Groups of 250 islets were incubated for 5 min at 37°C in 600,l of the physiological buffer containing 2 mm-or 20 mM-glucose, 1 mM-inositol and 10 mM-LiCl, in the absence or presence of 500 1M-CCh. Incubations were terminated by addition of 3 ml of icecold chloroform/methanol (2:1, v/v), followed by thorough vortex-mixing (1 min) and sonication (4 x 15 s). Aqueous and organic phases were separated by centrifugation (1000 g, 5 min) and the upper aqueous phase was removed, mixed with 2 ml of water and applied to a polypropylene column containing Dowex AGI-X8 (200-400 mesh; formate form) for ion-exchange chromatography (Best & Malaisse, 1983) . Free inositol and inositol phosphates were eluted from the columns by the stepwise addition of ammonium formate, as previously described (Berridge et al., 1983) . Free inositol was eluted with water, after which inositol monophosphates (IP1), inositol bisphosphates, and more phosphorylated forms, including inositol trisphosphates (IP3), were eluted with ammonium formate at concentrations of 0.2 M, 0.4 M and 1.0 M respectively. Radioactivity in column eluates and in the organic phase was determined by liquid-scintillation counting.
Statistical analysis
All results are expressed as means+ S.E.M. Differences between means were analysed by Student's paired or unpaired t tests or by analysis of variance, as appropriate, and considered significant when P < 0.05.
RESULTS
Effects of CCh on insulin secretion
Freshly isolated islets showed considerable variability in their responsiveness to CCh, as has been previously reported for the endogenous muscarinic agonist, ACh (Hughes et al., 1987) . Because of this, all further experiments with this agonist used islets which had been maintained in culture medium for 20-24 h, which restored the sensitivity of islets to CCh. As shown in Fig.  l(a) , the potentiating effect of CCh on glucose-induced insulin secretion was concentration-dependent, with maximal effects being obtained with about 100 /aM of the agonist. CCh enhancement of insulin secretion was also dependent on glucose concentration, with significant stimulatory effects being observed only when glucose was present at a concentration of 7 mm or higher, as shown in Fig. 1(b) . Perifusion of islets revealed that potentiation of secretion by CCh was a result of increase in both first and second phases of glucose-induced (20 mM) insulin release (Fig. 2) . Note also, consistent with the results obtained in static incubations, that at a sub-stimulatory concentration of glucose (2 mM), CCh had no significant effect on insulin secretion from perifused islets. Effects of CCh on PKC translocation Subcellular fractionation of islets revealed that in the unstimulated state (2 mM-glucose) most of the DE-52-purified PKC activity was associated with the cytosolic fraction ( Table 1) , and that the PKC activity was redistributed within the cells in response to CCh. Thus at 2 mM-glucose 4.4 + 2.00% (n = 5) of total PKC activity was associated with the membrane fractions. Exposure of islets to 20 mM-glucose for 5 min did not result in redistribution of PKC activity (4.1 + 1.5 00 of total activity associated with membranes). However, incubation of islets with 500 ,tM-CCh for 5 min, a concentration and time course over which CCh enhanced glucose-stimulated insulin secretion (see Figs. I and 2), resulted in significant increases in membrane-associated PKC activity in the presence of either 2 mm-or 20 mM-glucose (2 mMglucose + 500 /tM-CCh, 23+2.5 % of total; 20 mMglucose + 500 1tM-CCh, 16 + 2.1 00 of total; P < 0.05 ver- CCh significantly stimulated secretion at 5 mM-glucose in only one experiment (out of three), and in four experiments it had no effect on secretion at 2 mM-glucose. Significance of difference: *P < 0.05, **P < 0.0l, ***P <0.00l versus appropriate glucose concentration. (mean + S.E.M., n = 5) of controls (20 mM-glucose alone), whereas in PKC-depleted (PMA-treated) islets CCh only increased secretion by 43 + 9 o (P < 0.02 versus 4aPDD-treated). Note, however, that the decreased responses of PKC-depleted islets to CCh still represented a significant enhancement of insulin secretion (P < 0.05 versus paired 20 mM-glucose controls), whereas PMA pretreatment totally abolished any secretory response to a subsequent exposure to PMA (Table 2) . The decreased responsiveness of PKC-depleted islets to CCh did not appear to be due to impaired coupling of muscarinic receptors to phospholipase C, nor to direct inhibition of phospholipase C activity, since CCh stimulated production of [3H]inositol-containing compounds to a similar extent in control islets and in islets in which PKC activity had been depleted. Compared with total radioactivity (c.p.m.) in [3H]inositol-containing compounds eluted from the columns in the presence of 20 mM-glucose alone, [3H]inositol-labelled 4aPDD-treated islets showed a 42 + 20 increase and PMA-treated islets a 53+400 increase in response to 500 ,tM-CCh (means+ S.E.M., n = 3; P > 0.05). Thus, in the presence of 20 mM-glucose, CCh significantly stimulated the accumulation of IP1 and IP2 in both PMA-treated and 4aPDD-treated islets, as shown in Table 3 . Despite this, full potentiation of glucose-induced secretion from PMAtreated islets was not achieved even in the presence of 5 mM-CCh, a supramaximal stimulatory concentration of this agonist (Table 2) .
DISCUSSION
Pancreatic insulin secretion is enhanced in vivo by the release of ACh from parasympathetic fibres of the vagus nerve, which penetrate the islets and terminate close to the endocrine cells (see Miller, 1981 , for review). ACh and its non-hydrolysable analogue, CCh, also potentiate glucose-stimulated insulin release in vitro (Malaisse et al., 1967; Nenquin et al., 1984; Hughes et al., 1987) . It is known that these cholinergic agonists exert their effects by binding to specific muscarinic M2 receptors Verspohl et al., 1988) and that activation of these receptors, and potentiation of secretion, can be blocked by the muscarinic antagonist atropine (Malaisse et al., 1967; Gagerman et al., 1978; Mathias et al., 1985) . However, the sequence of events resulting from ,-cell muscarinic-receptor occupation that culminates in enhanced insulin secretion is not well-defined. Table 3 . Inositol phosphate generation in normal and PKC-depleted islets After labelling of islet phosphoinositides with [3H]inositol for 2 h, CCh stimulated significant increases in the incorporation of 3H into IP1 and IP2, in both 4aPDD-and PMA-treated islets: * indicates P < 0.05 versus appropriate 20 mM-glucose controls (n = 3 for all experiments). Basal unstimulated (2 mM-glucose) levels of IP1 and 1P2 were higher in PMA-treated than 40PDD-treated islets, perhaps reflecting a negative regulatory effect of PKC on phospholipase C in normal islets, which was relieved after PKC down-regulation. Exposure to PMA did not significantly affect 3H uptake into islets: 3502 +163 c.p.m./10 4aPDD-treated islets, 4733 +906 c.p.m./10 PMA-treated islets (P > 0.2). 
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In common with other reports (Gagerman et al., 1978; Mathias et al., 1985; Garcia et al., 1988) , we found that insulin secretion was enhanced by a muscarinic agonist in a dose-dependent manner. However, whereas most other studies (Gagerman et al., 1978; Nenquin et al., 1984; Mathias et al., 1985) reported effects of muscarinic agonists on secretion from freshly isolated islets, CCh did not consistently potentiate insulin release from rat islets under these conditions. Lack of response of freshly isolated islets to CCh may have been a result of fl-cell muscarinic-receptor damage during collagenase isolation of islets, as suggested by Hughes et al. (1987) . In contrast with the report by Meglasson et al. (1986) , where ACh elevated only the first phase of 10 mM-glucose-induced insulin secretion, but in accordance with the studies by Nenquin et al. (1984) we found that CCh potentiated both phases of insulin release. Furthermore, the inability of CCh to increase insulin secretion significantly at substimulatory glucose concentrations, observed both in static incubations and in perifusions, is in agreement with other reports that muscarinic agonists act as potentiators, rather than initiators, of insulin release (Nenquin et al., 1984; Morgan et al., 1985; Hughes et al., 1987) .
The major aim of the present study was to determine the involvement of PKC in the potentiation of insulin secretion by CCh. The stimulation of PKC translocation by CCh observed in the present experiments using normal rat islets is in accordance with recent reports of CChinduced PKC translocation in insulin-secreting tumour cells (Yamatani et al., 1988; Regazzi & Wollheim, 1988) . The redistribution of PKC presumably reflects generation of membrane-associated DAG, and is consistent with the report that CCh generates DAG in islets by activation of phospholipase C, a response that is maximal by 1 min and maintained for at least 5 min (Peter-Riesch et al., 1988) . In the present study, both insulin release and PKC redistribution were stimulated by CCh at times when it would be expected to increase DAG production, suggesting that the translocation of PKC to membranes may be an early event in cholinergic enhancement of insulin release.
Prolonged exposure to tumour-promoting phorbol esters has been shown specifically to down-regulate total PKC activity in islets of Langerhans (Hii et al., 1987; Metz, 1988) as well as other cell types (see Murray et al., 1987) , probably as a result of increased degradation of the enzyme without any change in its rate of synthesis (Young et al., 1987) . We have previously shown that incubation of islets with PMA for 5 min causes an increase in PKC activity associated with membrane fractions (Persaud et al., 1989) , and in this activated state the enzyme is susceptible to proteolytic cleavage by a Ca2"-activated neutral protease (Nishizuka, 1984) . In the present study, islets cultured overnight with 200 nM-PMA showed an approx. 9000 loss of PKC activity associated with the cytosolic fraction. This is consistent with translocation of enzyme activity followed by progressive degradation of membrane-associated PKC until virtually all PKC that was originally present in the cytosol had been activated and proteolytically cleaved. Down-regulation of islet PKC resulted in a significantly decreased secretory response to CCh, even at concentrations as high as 5 mm. However, under these conditions of negligible PKC activity, with islets which were totally unresponsive to the secretagogue effects of PMA, CCh caused a lesser, but still significant, potentiation of glucose-stimulated insulin release. These results are in agreement with those of in which H-7, an inhibitor of PKC activity, decreased, but did not abolish, the increment in insulin secretion in response to CCh at 8.3 mM-glucose.
Short-term exposure to PMA (5-15 min) has been reported to inhibit phospholipase-C-mediated hydrolysis of membrane phosphoinositides in many cell types, including insulin-secreting tumour cells (Biden et al., 1988) . This action is thought to be mediated by activation of PKC resulting in either a decrease in receptor number (Lynch et al., 1985) or impaired G-protein-phospholipase-C coupling (Orellana et al., 1987) . However, such a negative-feedback effect of PKC activation cannot account for the decreased secretory response to CCh after treatment of islets with PMA for > 20 h in the present studies, because CCh was able to stimulate phospholipase-C activity in these islets, as assessed by increased generation of [3H]inositol phosphates. In any case, PKC-mediated down-regulation of phospholipase-C activity as a result of PMA treatment would be expected to be a short-term effect, because PKC within islets is depleted in the continued presence of PMA. Thus any PKC-dependent inhibition of phosphoinositide hydrolysis should not be maintained.
The results of our experiments with PKC-depleted islets suggest that PKC is not the only mechanism through which CCh modulates glucose-stimulated insulin release, but that activation of this enzyme by CCh promotes a full potentiation of secretion. Several other observations suggest the involvement of a mechanism(s) other than PKC activation in the action of cholinergic agonists on fl-cells. For example, in the present study, CCh did not initiate insulin secretion at 2 mM-glucose, despite its ability to induce redistribution of PKC activity at this sub-stimulatory glucose concentration, suggesting that activation and redistribution of PKC is insufficient to initiate insulin secretion. Similarly, in the absence of a stimulatory concentration of glucose, CCh stimulated mobilization ofintracellular Ca2l in rat islets, presumably as a result of inositol trisphosphate generation, but it did not stimulate insulin secretion under the same conditions (Morgan et al., 1985) .
In the mouse f-cell ACh augments insulin secretion only when the ,-cell plasma membrane has been depolarized by glucose or other primary stimuli (Hermans et al., 1987) . It has therefore been proposed that ACh potentiates insulin release by increasing the fl-cell membrane permeability to Na+ ions, resulting in further membrane depolarization and enhanced influx of Ca2" . However, further studies by Henquin and co-workers have shown that, at a supramaximal concentration of glucose (30 mM), ACh has only minor effects on Ca2" influx and yet markedly augments the secretory response 
